LON:GENF Genflow Biosciences (GENF) Share Price, News & Analysis GBX 0.80 +0.03 (+3.23%) As of 12:02 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsBuy This Stock About Genflow Biosciences Stock (LON:GENF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Genflow Biosciences alerts:Sign Up Key Stats Today's Range 0.76▼ 0.8050-Day Range 0.79▼ 1.1452-Week Range 0.75▼ 3.10Volume24,755 shsAverage Volume2.61 million shsMarket Capitalization£2.73 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewGenflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs. The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.Read More… Receive GENF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Genflow Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address GENF Stock News HeadlinesGenflow Biosciences PLC (GENF)April 6, 2023 | investing.comCompanies Like Genflow Biosciences (LON:GENF) Can Afford To Invest In GrowthApril 6, 2023 | finance.yahoo.comSee More Headlines GENF Stock Analysis - Frequently Asked Questions How have GENF shares performed this year? Genflow Biosciences' stock was trading at GBX 1.80 on January 1st, 2025. Since then, GENF shares have decreased by 55.6% and is now trading at GBX 0.80. View the best growth stocks for 2025 here. How were Genflow Biosciences' earnings last quarter? Genflow Biosciences plc (LON:GENF) released its earnings results on Wednesday, April, 30th. The company reported ($0.47) EPS for the quarter. Genflow Biosciences had a net margin of 778.46% and a negative trailing twelve-month return on equity of 208.12%. How do I buy shares of Genflow Biosciences? Shares of GENF stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Genflow Biosciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Genflow Biosciences investors own include Aehr Test Systems (AEHR), Advanced Micro Devices (AMD), ARM (ARM), Medical Properties Trust (MPW), NIO (NIO), NVIDIA (NVDA) and PayPal (PYPL). Company Calendar Last Earnings4/30/2025Today6/18/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:GENF CIKN/A Webgenflowbio.com Phone44 32 4774 95881FaxN/AEmployees5Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.53) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-£1.76 million Net Margins778.46% Pretax MarginN/A Return on Equity-208.12% Return on Assets-58.66% Debt Debt-to-Equity RatioN/A Current Ratio3.09 Quick Ratio20.20 Sales & Book Value Annual Sales-£226.19 thousand Price / Sales-12.06 Cash FlowGBX 0.27 per share Price / Cash Flow3.00 Book ValueGBX 0.25 per share Price / Book3.22Miscellaneous Outstanding Shares340,919,077Free FloatN/AMarket Cap£2.73 million OptionableNot Optionable Beta2.37 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (LON:GENF) was last updated on 6/18/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump Makes Major Crypto AnnouncementPay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift ...Crypto 101 Media | SponsoredElon’s End Game Is Going Live -- And It Could Make You a FortuneThe media and the so-called experts have laughed at Elon Musk his entire career. CBS called PayPal “one of ...The Oxford Club | SponsoredSorry about the swear wordWhat a huge few months for Bitcoin. First, Bitcoin hit $100,000… Then, Donald Trump pledged to create an...Manward Press | SponsoredThe Dollar Reset Nobody’s Talking AboutCould this man take down the financial system? In March, the Senate granted sweeping powers to a Harvard ec...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genflow Biosciences plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Genflow Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.